Opportunity Information: Apply for RFA DA 16 004

  • The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Harnessing Genome Editing Technologies to Functionally Validate Genetic Variants in Substance Use Disorders (R21/R33)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279 Drug Abuse and Addiction Research Programs.
  • This funding opportunity was created on May 27, 2015 and posted on May 27, 2015.
  • Applicants must submit their applications by Aug 25, 2015. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • The funding agency has allocated a total of $2,000,000.00 to eligible and selected applicants.
  • Eligible applicants include: Independent school districts State governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Private institutions of higher education Public and State controlled institutions of higher education County governments Public housing authorities/Indian housing authorities Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Native American tribal governments (Federally recognized) Native American tribal organizations (other than Federally recognized tribal governments) Special district governments Others (see text field entitled Additional Information on Eligibility for clarification) For profit organizations other than small businesses.
  • Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
Apply for RFA DA 16 004

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The NIH funding opportunity "Harnessing Genome Editing Technologies to Functionally Validate Genetic Variants in Substance Use Disorders (R21/R33)" (Funding Opportunity Number RFA-DA-16-004) is a discretionary grant program designed to accelerate research that moves beyond simply identifying genetic or epigenetic signals associated with substance use disorders and into testing what those signals actually do. The central aim is to apply genome editing and epigenome editing approaches to functionally validate and characterize specific genetic or epigenetic variants that may influence risk for, progression of, or resilience to substance use disorders. In practical terms, the program is focused on turning statistical associations and candidate variants into experimentally supported biological mechanisms, ideally linking variants to changes in gene regulation, neural circuit function, cellular phenotypes, or other measurable neurobiological outcomes relevant to addiction.

A key feature of the opportunity is its emphasis on generating research resources that will not remain limited to a single lab. The announcement specifically highlights that genetic resources produced through funded projects should be made broadly available to the scientific community. This reflects an expectation that investigators will create tools such as edited cell lines, engineered model systems, validated variant constructs, or other shareable reagents and datasets that other researchers can use to probe addiction-related pathways more deeply. The broader purpose is to build a foundation of well-characterized, community-accessible resources that can speed up discovery across the field, making it easier to test hypotheses about how particular variants, genes, or pathways contribute to addiction biology.

The scientific motivation behind the initiative is that substance use disorders have complex genetic and epigenetic architectures, and many associated variants may lie in noncoding or regulatory regions where functional consequences are harder to infer. By encouraging the use of genome and epigenome editing technologies, the program seeks to enable more precise cause-and-effect experiments, such as introducing or correcting specific variants and observing downstream effects. Ultimately, the knowledge generated is intended to support long-term goals that include improved prevention strategies, better diagnostics, and the identification of novel therapeutic targets, all grounded in a clearer understanding of neurobiological mechanisms.

This opportunity uses the NIH R21/R33 funding mechanism, which is typically structured to support an initial exploratory or developmental phase (R21) followed by a second phase (R33) for expanded activities once early milestones are met. While the specific milestone structure and transition criteria are defined in the full announcement, the general intent of this paired mechanism is to encourage innovative, higher-risk early work that can mature into more robust, systematic functional studies within the same award pathway.

Administratively, the opportunity was posted on May 27, 2015, with an original and current closing date of August 25, 2015, and an archive date of September 25, 2015. The estimated total funding amount listed is $2,000,000. It falls under CFDA number 93.279, Drug Abuse and Addiction Research Programs, and cost sharing or matching is not required. The sponsoring agency is the National Institutes of Health, and the primary subject area aligns with health and drug abuse/addiction research.

Eligibility is broad and includes many types of domestic institutions and organizations, as well as certain non-U.S. entities. Eligible applicants include public and state-controlled institutions of higher education, private institutions of higher education, nonprofits with and without 501(c)(3) status (including those other than institutions of higher education), small businesses, other for-profit organizations (excluding small businesses as a separate category), state governments, county governments, city or township governments, independent school districts, special district governments, public and Indian housing authorities, federally recognized Native American tribal governments, and other tribal organizations. The eligibility information also notes additional eligible categories such as historically Black colleges and universities (HBCUs), Hispanic-serving institutions, tribally controlled colleges and universities (TCCUs), Alaska Native and Native Hawaiian-serving institutions, Asian American and Native American Pacific Islander-serving institutions (AANAPISIs), faith-based or community-based organizations, regional organizations, eligible federal agencies, U.S. territories or possessions, and foreign (non-domestic) entities.

For applicants or readers who need the official posting and full requirements, the announcement provides an additional information link through the NIH grants guide (http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-16-004.html). The contact listed for access or linking problems is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.

Frequently Asked Questions (FAQs)

What is the name of this NIH funding opportunity?

The opportunity is titled "Harnessing Genome Editing Technologies to Functionally Validate Genetic Variants in Substance Use Disorders (R21/R33)."

What is the funding opportunity number?

The Funding Opportunity Number is RFA-DA-16-004.

Which agency is sponsoring this grant program?

The sponsoring agency is the National Institutes of Health (NIH).

What is the overall purpose of this grant program?

The program is designed to accelerate research that moves beyond identifying genetic or epigenetic signals associated with substance use disorders and into testing what those signals do. It emphasizes using genome editing and epigenome editing approaches to functionally validate and characterize specific variants that may affect risk, progression, or resilience in substance use disorders.

What kinds of research questions is NIH trying to encourage through this opportunity?

This opportunity is aimed at turning statistical associations and candidate variants into experimentally supported biological mechanisms. The intent is to link variants to measurable outcomes such as changes in gene regulation, neural circuit function, cellular phenotypes, or other neurobiological effects relevant to addiction.

Why does the announcement emphasize genome editing and epigenome editing?

Substance use disorders often involve complex genetic and epigenetic architectures, and many associated variants may be in noncoding or regulatory regions where functional consequences are difficult to infer. Genome and epigenome editing approaches are emphasized because they support more direct cause-and-effect experiments (for example, introducing or correcting a specific variant and observing downstream effects).

What types of outcomes does the program hope to enable in the long term?

The knowledge generated is intended to support long-term goals including improved prevention strategies, better diagnostics, and identification of novel therapeutic targets, grounded in clearer understanding of neurobiological mechanisms related to addiction.

Does this funding opportunity require that resources be shared with other researchers?

Yes. A key feature is an emphasis on generating genetic research resources that will not remain limited to a single lab. The announcement highlights that resources produced through funded projects should be made broadly available to the scientific community.

What kinds of shareable research resources does the opportunity anticipate?

The announcement points to tools such as edited cell lines, engineered model systems, validated variant constructs, and other shareable reagents and datasets that can be used by other researchers to investigate addiction-related pathways.

What funding mechanism is used for this opportunity?

This opportunity uses the NIH R21/R33 funding mechanism.

How is the R21/R33 mechanism generally structured?

It is typically structured as an initial exploratory or developmental phase (R21) followed by a second phase (R33) for expanded activities once early milestones are met. The specific milestone structure and transition criteria are defined in the full announcement.

Is this a discretionary grant program?

Yes. It is described as a discretionary grant program.

What is the estimated total funding amount listed for this opportunity?

The estimated total funding amount listed is $2,000,000.

What CFDA number is associated with this opportunity?

The CFDA number is 93.279, Drug Abuse and Addiction Research Programs.

Is cost sharing or matching required?

No. Cost sharing or matching is not required.

When was this opportunity posted?

The opportunity was posted on May 27, 2015.

What was the closing date for applications?

The original and current closing date listed is August 25, 2015.

When was the opportunity archived?

The archive date listed is September 25, 2015.

What is the primary subject area for this funding opportunity?

The primary subject area aligns with health and drug abuse/addiction research.

Who is eligible to apply?

Eligibility is broad and includes many types of domestic institutions and organizations, as well as certain non-U.S. entities. Eligible applicants include:

  • Public and state-controlled institutions of higher education
  • Private institutions of higher education
  • Nonprofits with 501(c)(3) status (including those other than institutions of higher education)
  • Nonprofits without 501(c)(3) status (including those other than institutions of higher education)
  • Small businesses
  • Other for-profit organizations (excluding small businesses as a separate category)
  • State governments
  • County governments
  • City or township governments
  • Independent school districts
  • Special district governments
  • Public and Indian housing authorities
  • Federally recognized Native American tribal governments
  • Other tribal organizations

Are minority-serving institutions and community organizations included in eligibility?

Yes. The eligibility information also notes additional eligible categories such as historically Black colleges and universities (HBCUs), Hispanic-serving institutions, tribally controlled colleges and universities (TCCUs), Alaska Native and Native Hawaiian-serving institutions, Asian American and Native American Pacific Islander-serving institutions (AANAPISIs), faith-based or community-based organizations, and regional organizations.

Are U.S. territories or possessions eligible to apply?

Yes. U.S. territories or possessions are listed among eligible categories.

Are foreign (non-domestic) entities eligible to apply?

Yes. Foreign (non-domestic) entities are listed among eligible categories.

Are federal agencies eligible applicants under this opportunity?

Yes. Eligible federal agencies are included among the additional eligible categories noted in the eligibility information.

Where can applicants find the official NIH posting and full requirements?

The announcement provides an NIH Grants Guide link for additional information: http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-16-004.html.

Who should be contacted for access or linking problems related to the official announcement?

The contact listed is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education Health

Next opportunity: Montana Arctic Grayling Conservation

Previous opportunity: Strengthening the Operating Framework and Furthering the Objectives of Coalition For Accelerating Standards And Therapies (CFAST) Initiative (U24)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA DA 16 004

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (RFA DA 16 004) also looked into and applied for these:

Funding Opportunity
Tools and Services for Designing Methodologically Rigorous Animal Studies (R41/R42) Apply for RFA DA 16 002

Funding Number: RFA DA 16 002
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Tools and Services for Designing Methodologically Rigorous Animal Studies (R43/R44) Apply for RFA DA 16 003

Funding Number: RFA DA 16 003
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Career Development Program in Emergency Care Research (K12) Apply for RFA HL 16 019

Funding Number: RFA HL 16 019
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Harnessing Big Data to Halt HIV (R01) Apply for PA 15 273

Funding Number: PA 15 273
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Smoking Cessation within the Context of Lung Cancer Screening (R01) Apply for RFA CA 15 011

Funding Number: RFA CA 15 011
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $500,000
Ethical Issues in Research on HIV/AIDS and its Co Morbidities (R01) Apply for PAR 15 274

Funding Number: PAR 15 274
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Ethical Issues in Research on HIV/AIDS and its Co Morbidities (R21) Apply for PAR 15 275

Funding Number: PAR 15 275
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
Turkey US Collaborative Program for Affordable Medical Technologies (R01) Apply for PAR 15 276

Funding Number: PAR 15 276
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $100,000
Multidisciplinary Studies of HIV/AIDS and Aging (R01) Apply for PAR 15 280

Funding Number: PAR 15 280
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Multidisciplinary Studies of HIV/AIDS and Aging (R03) Apply for PAR 15 281

Funding Number: PAR 15 281
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $50,000
Multidisciplinary Studies of HIV/AIDS and Aging (R21) Apply for PAR 15 282

Funding Number: PAR 15 282
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
Extracellular Vesicles and Substance Abuse (R21) Apply for PAR 15 284

Funding Number: PAR 15 284
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
Extracellular Vesicles and Substance Abuse (R01) Apply for PAR 15 283

Funding Number: PAR 15 283
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $350,000
The Pancreatic Cancer Detection Consortium (U01) Apply for PAR 15 289

Funding Number: PAR 15 289
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01) Apply for PAR 15 297

Funding Number: PAR 15 297
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Tools for Monitoring and Manipulating Modified RNAs in the Nervous System (R43/R44) Apply for RFA DA 16 005

Funding Number: RFA DA 16 005
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Tools for Monitoring and Manipulating Modified RNAs in the Nervous System (R41/R42) Apply for RFA DA 16 006

Funding Number: RFA DA 16 006
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Supplements to Support Evaluation of the NCI Cancer Genomics Cloud Pilots (Admin Supp) Apply for PA 15 305

Funding Number: PA 15 305
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $40,000
Physical Activity and Weight Control Interventions Among Cancer Survivors Effects on Biomarkers of Prognosis and Survival (R01) Apply for PA 15 311

Funding Number: PA 15 311
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Physical Activity and Weight Control Interventions Among Cancer Survivors Effects on Biomarkers of Prognosis and Survival (R21) Apply for PA 15 310

Funding Number: PA 15 310
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA DA 16 004", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.